The transcription factor hypoxia inducible factor 1 (HIF1), an HIF1a-aryl hydrocarbon receptor nuclear translocator (ARNT) dimeric factor, is essential to the cellular response to hypoxia. We described a t(1;12)(q21;p13) chromosomal translocation in human acute myeloblastic leukemia that involves the translocated Ets leukemia (TEL/ETV6) and the ARNT genes and results in the expression of a TEL-ARNT fusion protein.
The transcription factor hypoxia inducible factor 1 (HIF1), an HIF1a-aryl hydrocarbon receptor nuclear translocator (ARNT) dimeric factor, is essential to the cellular response to hypoxia. We described a t(1;12)(q21;p13) chromosomal translocation in human acute myeloblastic leukemia that involves the translocated Ets leukemia (TEL/ETV6) and the ARNT genes and results in the expression of a TEL-ARNT fusion protein.
Functional studies show that TEL-ARNT interacts with HIF1a and the complex binds to consensus hypoxia response element. In low oxygen tension conditions, the HIF1a/TEL-ARNT complex does not activate transcription but exerts a dominant-negative effect on normal HIF1 activity. Differentiation of normal human CD34 þ progenitors cells along all the erythrocytic, megakaryocytic and granulocytic pathways was accelerated in low versus high oxygen tension conditions. Murine 32Dcl3 myeloid cells also show accelerated granulocytic differentiation in low oxygen tension in response to granulocyte colony-stimulating factor. Interestingly, stable expression of the TEL-ARNT in 32Dcl3 subclones resulted in impaired HIF1-mediated transcriptional response and inhibition of differentiation enhancement in hypoxic conditions. Taken together, our results underscore the role of oxygen tension in the modulation of normal hematopoietic differentiation, whose targeting can participate in human malignancies.
Introduction
Oxygen homeostasis is an important organizer for human development and physiology. The hypoxia inducible factor 1 (HIF1) is a major player in the cellular transcriptional response to hypoxia, leading to both local and systemic responses. Hypoxia inducible factor 1 is a dimeric factor composed from HIF1a and aryl hydrocarbon receptor nuclear translocator (ARNT1) subunit (Hoffman et al., 1991; Wang et al., 1995) . They belong to a subclass of the basic region helix-loop-helix (bHLH) transcription factor family sharing Per, ARNT, Sim (PAS) domains. Regulation of HIF1a stability and activity is essential to the modulation of HIF1. In high oxygen tension conditions (20% O 2 ), HIF1a is unstable and is driven to proteasome degradation through interaction with the VHL (von Hippel-Lindau) gene product. The interaction between VHL and HIF1a is tightly regulated by prolyl hydroxylation of the latter and HIF1a interaction with the CBP coactivator is also posttranslationally regulated by arginine hydroxylation (see Safran and Kaelin, 2003 for review) . The HIF1a/ARNT dimer activates transcription through the hypoxia response element (HRE: TACGTG) in the promoter or enhancer region of target genes that include vascular endothelial growth factor (VEGF), erythropoietin and phosphoglycerate kinase (PGK). In mammals, HIF1 is required for the establishment and utilization of the placenta, cartilage, erythroid, vascular, cardiac and respiratory systems (Maltepe et al., 1997; Iyer et al., 1998; Ryan et al., 1998; Kotch et al., 1999; Kline et al., 2002; Kojima et al., 2002; Ramirez-Bergeron et al., 2004) . In keeping with this fundamental role in normal development, HIF1 activity has also been associated with human diseases. Hypoxia inducible factor 1 is overexpressed in several human cancers leading to an increased expression of VEGF. Expression of VEGF is required to stimulate angiogenesis and solid tumor vascularization, a critical step in tumor progression and also in hematologic malignancies (Semenza, 2000; Maxwell et al., 2001) . Intrinsically, hypoxic conditions in solid tumors are supposed to allow selection for P53 mutations (Graeber et al., 1996; An et al., 1998) .
In some instances, oncogenic mutations have been shown to result in increased HIF1 activity. For example, v-Src and Ras mutations lead to VEGF expression through HIF1 stimulation, perhaps via the activation of the PI3K/Akt pathway. Moreover, in human prostate cancer, loss of the tumor suppressor PTEN, which exerts a negative control on the PI3K/Akt pathway, is correlated with angiogenesis. Loss of P53 also leads to an increase of the hypoxia response (see Harris, 2002 for review) .
The translocated ets leukemia (TEL/ETV6) gene (Golub et al., 1994) is frequently rearranged as a result of chromosomal abnormalities present in human malignancies. Most of these abnormalities induce the expression of fusion proteins between TEL sequences and amino-acid sequences encoded by the partner gene (Rubnitz et al., 1999; Salomon-Nguyen et al., 2000 and references therein). The largest class of TEL's partner genes encodes protein tyrosine kinases whose catalytic domains are fused to the amino-terminal part of TEL. The TEL moiety induces polymerization of the fusion proteins, leading to constitutive kinase activity Jousset et al., 1997; Lacronique et al., 1997; Kim et al., 2001) . The other class of TEL's partner genes encodes transcription factors such as RUNX1/AML1, which codes for a DNA binding subunit of the core binding factor (CBF; Speck, 2001 ). The TEL-AML1 fusion protein oligomerizes and exhibits repressive transcription properties and dominant-negative effect on normal AML1 activity (Hiebert et al., 1996; Fenrick et al., 1999) . We recently described a TEL-ARNT fusion protein in a case of human acute myeloblastic leukemia (AML; Salomon-Nguyen et al., 2000) . We now report the biochemical and biological properties of the TEL-ARNT fusion protein in the HIF1 context and demonstrate that the modulation of normal human hematopoietic cell differentiation by oxygen tension can be directly targeted by human oncogenic events.
Results

Functional analyses of the TEL-ARNT fusion protein
Because HIF1a is ubiquitously expressed and transcribed in t(1;12) patient sample and in all the hematopoietic cell lines tested (Salomon-Nguyen et al., 2000) , we decided to compare the biochemical properties of TEL-ARNT to those of ARNT, with respect to HIF1 activity. Transfection studies confirmed a nuclear localization for the TEL-ARNT protein (data not shown). In addition, TEL-ARNT was able to interact with the normal ARNT partner HIF1a, as demonstrated by co-immunoprecipitation experiments using in vitro translated proteins (Supplementary Figure 1) .
We used in vitro-translated products in electrophoretic mobility shift assay (EMSA) to examine the DNA binding properties of the HIF1a/TEL-ARNT dimer to the HRE probe. As shown in Figure 1a , when HIF1a and TEL-ARNT are coexpressed, a shifted complex is observed with a labelled HRE probe (lane 3). This complex is specific as it disappeared upon competition with a 100-fold molar excess of unlabelled HRE probe used as competitor (lane 4), but not in the presence of a same excess of competitor probe mutated in the HRE core sequence (M18, lane 8). Supershift experiments using antibodies specific for the carboxy-terminal part of ARNT (lane 5) and Myc-tagged HIF1a protein (lane 6) demonstrated the presence of both TEL-ARNT and HIF1a proteins in the complex. As expected, coexpression of HIF1a and ARNT resulted in the interaction of an HIF1a/ARNT complex with HRE as shown in Figure 1a (right panel, lanes 9-19).
To check for TEL-ARNT and HIF1a interaction in vivo, co-immunoprecipitation experiments from transiently transfected 293T cells were performed. As shown in Figure 1b , TEL-ARNT was precipitated using antiMyc antibody only when Myc-HIF1a was coexpressed (upper panel). Reciprocally, the HIF1a protein was precipitated by the anti-ARNT immune serum only when TEL-ARNT was coexpressed ( Figure 1b , lower panel). Mimicking low oxygen tension condition by addition of deferoxamin (DFO) increased the amount of HIF1a irrespective of the presence or absence of TEL-ARNT. This indicates that TEL-ARNT and HIF1a association occurs in vivo but does not markedly interfere with the normal processes regulating HIF1a stability.
To investigate the transcriptional regulatory properties of the TEL-ARNT protein, we performed transient transfection experiments using a luciferase reporter construct driven by the human VEGF promoter (pVEGF-Luc). As shown in Supplementary Figure 2 , transfection of an ARNT expression vector enhanced the transactivation of the reporter in DFO and in response to low oxygen tension (1% O 2 ; Figure 1c and Supplementary Figure 2) . No transcriptional response to low oxygen tension conditions was observed using a reporter vector in which the HRE site was mutated (data not shown, Forsythe et al., 1996) . As addition of DFO and low-oxygen conditions (1% O2) appeared to result in qualitatively similar transcriptional responses ( Supplementary Figure 2) , the following experiments were performed in the presence of DFO.
In contrast, to the stimulatory effect of ARNT, the expression of TEL-ARNT failed to enhance the HREdependent transcriptional response of pVEGF-luc, despite the fact that it was expressed at similar levels as ARNT (Figure 1e and Supplementary Figure 2) .
To further characterize the properties of TEL-ARNT, comparison of the dose-response of pVEGF-Luc was performed. As shown in Figure 1c , transfection of increasing amounts of ARNT expression vector resulted in higher transcriptional response in the presence of DFO, whereas the same amount of TEL-ARNT expression vector failed to activate transcription and even inhibited it at high doses. In addition, we investigated the effect of TEL-ARNT expression on ARNT-induced enhancement of pVEFG-Luc activity. As shown in Figure 1d , the ARNT-dependent transcriptional activation of VEGF-Luc reporter gene construct TEL-ARNT interferes with cellular differentiation F Nguyen-Khac et al was severely impaired when increasing amounts of TEL-ARNT expression vectors are transfected together with a fixed amount of ARNT.
Taken together, these data establish that the TEL-ARNT fusion protein is able to interact with HIF1a and to bind the HRE as an HIF1a/TEL-ARNT complex. This complex is not able to activate HRE-dependent transcription response in low-oxygen conditions. Instead, the TEL-ARNT fusion protein exerts a dominant-negative effect upon the activity of wildtype ARNT in response to hypoxia. As judged from Western blot analyses of leukemic cells with t(1;12), the TEL-ARNT/ARNT expression ratio is highly in favor of TEL-ARNT (see Figure 1 , Salomon-Nguyen et al., 2000) , suggesting that HIF1a is trapped in a nonfunctional complex.
The TEL moiety, which is present and functional in the TEL-ARNT fusion protein, has been shown to possess both strong polymerization and transcriptional repression properties (Jousset et al., 1997; Lacronique et al., 1997; Salomon-Nguyen et al., 2000; Kim et al., 2001) . To investigate whether oligomerization or repression properties would be important for the TEL-ARNT activity, we fused a Gal4 DNA binding domain with the 
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F Nguyen-Khac et al amino-terminal extremity of the wild-type ARNT protein ( Figure 1e ). This protein domain is known to act as a dimerizing interface but is devoid of transcriptional repression properties. As shown in Figure 2a , the GAL4-ARNT protein transactivated a UAS G -responsive reporter gene in a dose-dependent fashion, consistent with the presence of a transcriptional activation domain in ARNT. In contrast, when tested on pVEGFLuc, the GAL4-ARNT fusion protein inhibited HREdependent transcription as efficiently as TEL-ARNT (Figure 2b ). These data suggest that dimerization of ARNT (induced by the GAL4 or TEL oligomerization domains) protein is critical to its ability to repress HIF1 activity.
Oxygen tension modulates hematopoietic cell differentiation Hypoxia inducible factor 1-mediated modulation of hematopoietic progenitor behavior by oxygen tension has been reported (Adelman et al., 1999) . TEL-ARNT impairment of HIF1 activity could contribute to its tumorigenic potential by affecting the balance of progenitor cells self-renewal and differentiation.
To confirm the role of oxygen tension in hematopoietic cell differentiation, we used normal human CD34 þ cord blood cells. CD34 þ sorted cells can be induced to differentiate into different lineages in response to specific cytokines. We first compared the proliferation and differentiation ability of CD34 þ cells induced toward erythrocytic and megakaryocytic lineages in high and low oxygen tension conditions. Low oxygen tension enhanced differentiation along both pathways, with respect to high oxygen tension conditions (Supplementary Figure 3) .
To study granulocytic differentiation, purified CD34 þ cells were grown in medium supplemented with interleukin (IL)3, G-CSF, stem cell factor and Flt3-ligand for 4 days and then switched to either highor low-oxygen conditions. Cells were analysed over a period of 6 days for their proliferation rate. Differentiation was assessed by morphological criteria and the expression of CD11, CD14 and CD15 myeloid differentiation markers. Higher cell numbers are observed in low as compared to high oxygen tension conditions (three times at day 6; Supplementary Figure 4) . When analysed for myeloid differentiation by morphological examination, a faster cell differentiation along the granulocytic pathway was observed in low as compared to high oxygen tension conditions (2.5-fold more differentiated cells at day 6; Figure 3a and b). This is paralleled by a faster accumulation of CD11b þ cells cultured in low oxygen tension (two times at day 5; Figure 3c ). Analyses of CD14 and CD15 markers led to similar conclusions (data not shown).
These observations indicate that low oxygen tension markedly favors differentiation of human normal hematopoietic cells along different lineages.
We investigated whether oxygen tension also modulates the differentiation of the murine leukemic cell line 32Dcl3. These myeloid IL3-dependent cells can be induced along the granulocytic differentiation pathway upon granulocyte colony-stimulating factor (G-CSF) stimulation and IL3 removal. We compared the course of G-CSF-induced differentiation of wild-type 32Dcl3 cells in low-and high-oxygen conditions. Morphological analyses, as shown in Figure 3d and e, clearly show that low oxygen tension conditions enhanced the differentiation (three times 5 days after the induction of differentiation) of these cells, as compared to high-oxygen conditions. Similar observations can be made when differentiation was monitored using expression of the myeloid cell surface antigen CD11b. Figure 3f shows the time course of the appearance of CD11b-expressing cells, which is faster in low-versus high-oxygen conditions. Therefore, in this model, low oxygen tension results in a marked enhancement of differentiation at day 4, following G-CSF stimulation of wild-type 32Dcl3 cells. The 32Dcl3 cell line therefore represents a suitable model to address whether the TEL-ARNT fusion protein would interfere with the modulation of granulocytic differentiation by oxygen tension. GAL4-ARNT chimeric protein is able to activate transcription from a GAL4 reporter construct, whereas GAL4 or wild-type ARNT is not. Amounts were 10, 100 and 400 ng of plasmid expression vector. (b) In the presence of deferoxamin (DFO), transfection of similar amounts of TEL-ARNT or GAL4-ARNT expression vector does not stimulate the transcriptional activity of the VEGF promoter in contrast to ARNT, indicating that dimerization of ARNT abolishes its transcriptional activity specifically toward hypoxia response element (HRE), but not toward UAS.
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In that purpose, we isolated three independent 32Dcl3 clones that stably express the TEL-ARNT fusion protein (TA1, TA2, TA3; Figure 4a ) and two control clones transduced with the corresponding empty expression vector (clones P1 and P2; Figure 4a ). The HIF1 activity was analysed in these clones by monitoring the induction of Glut1, a known HIF1 target gene, in response to hypoxia. As expected, Glut1 expression was induced in response to low oxygen tension in both parental cell line and control clones. In contrast, Glut1 induction by low oxygen tension was markedly impaired in TEL-ARNT-expressing cells, indicating that TEL-ARNT is functional in these cells (Figure 4b ). Analyses of VEGF expression led to similar conclusions (data not shown). These clones were then compared for their proliferation and differentiation properties in high versus low oxygen tension conditions. No obvious proliferation differences were observed between those clones either in low-or high-oxygen conditions (data not shown).
We next compared the differentiation of the 32Dcl3 control and TEL-ARNT expressing-clones in low and high oxygen tension conditions. Cell surface expression of CD11b antigen was compared between normoxic and hypoxic conditions at day 4. The results of a representative experiment, presented as ratios of CD11b-positive cells in hypoxic/CD11b-positive cells in normoxic conditions, are summarized Figure 4c . Hypoxia enhancement of differentiation is consistently lower in TEL-ARNT-expressing 32Dcl3 clones (less than two times) as compared to the two control clones (2.5 and 4.5 times). Morphological analyses of the subclones corroborated these conclusions (data not shown).
Discussion
Our initial observation in a human AML of the M2 FAB subtype of a fusion protein, consisting of the first 154 amino acids of TEL and all but the first eight amino acids of the wild-type ARNT, suggested that the targeting of the HIF1a/ARNT normal dimer activity could participate in the malignant process (SalomonNguyen et al., 2000) . Accordingly, the TEL-ARNT protein is able to form an HIF1 type dimer by interacting with HIF1a and to bind the normal DNA response element of HIF1. However, in transient cotransfection assays, the HIF1a/TEL-ARNT dimer is not able to activate transcription from the human VEGF promoter, a natural HIF1-responsive promoter. Rather, TEL-ARNT exhibits dose-dependent dominant-negative properties toward the wild-type HIF1 dimer. Two lines of evidence indicate that this property is relevant to TEL-ARNT activity in vivo. First, Western blotting analyses of t(1;12) leukemic cells showed considerably higher level of TEL-ARNT fusion protein with respect to wild-type ARNT (Salomon-Nguyen et al., 2000) . Second, myeloid cells stably expressing the TEL-ARNT protein demonstrated an impaired transcriptional response to hypoxia of endogenous cellular genes in their normal chromatin context. The combination of high ratio for TEL-ARNT with respect to ARNT proteins in leukemic cells and the ability of TEL-ARNT to bind HIF1a and sequester in nonfunctional oligomers could severely impair the response of HIF1 target promoters. Dominant negative properties on normal AML1 have also been demonstrated for the fusion protein TEL-AML1 (Hiebert et al., 1996) . A major structural difference between TEL-AML1 and TEL-ARNT is the absence of the central part of TEL (amino acids 155-331) in TEL-ARNT. This domain of TEL is endowed with autonomous transcriptional repression properties that rely on the recruitment of corepressor/HDAC multiprotein complexes. Like TEL-ARNT, an artificial fusion between the yeast GAL4 DNA dimerization domain and ARNT protein failed to activate transcription from the VEGF promoter. Because the GAL4 dimerization/DNA binding domain is neutral with respect to transcriptional regulation, our observations suggest that the oligomerization induced by the TEL moiety is a major determinant of its interference with ARNT function.
We observed an acceleration of granulocytic differentiation in low oxygen tension conditions, with respect to 20% oxygen tension. This hypoxia-dependent increase in differentiation was markedly impaired in 32Dcl3 clones expressing the TEL-ARNT fusion protein when compared to wild-type 32Dcl3 subclones transfected with the empty vector. Our results support a model in which TEL-ARNT participate in leukemogenesis by interfering with cell differentiation. Interference with hypoxia-responsive differentiation may be widely involved in leukemia initiation and progression. For example, it is postulated that CMYC and HIF1 share common target genes (Dang and Semenza, 1999) and VEGF was recently presented as an indirect CMYC target gene (Baudino et al., 2002) . Whether CMYC and hypoxia common target genes play a role in leukemogenesis remains to be determined. It has been proposed that AML3, a CBFA subunit specific for bone tissue, is involved in the control of the cellular response to hypoxia (Zelzer et al., 2001) . Consistently, a crosstalk between AML1-ETO and the cellular response to hypoxia has recently been described, impacting on the transcriptional control of cellular differentiation (Jiang et al., 2005) . This might also be the case for other fusion oncoproteins, such as PML-RARa (Liu et al., 2006) . Also the P14/P19-P53 cell cycle control pathway can be suggested as a connection point for both hypoxia and CBF fusion oncoproteins (Harris, 2002; Lacaud et al., 2002; Linggi et al., 2002) .
The role of oxygen tension on cellular differentiation is not restricted to the hematopoietic system (Kroon et al., 2001; Li et al., 2002; Gustafsson et al., 2005) . Interestingly, several known hypoxia-activated genes, such as those encoding proteins involved in glucose metabolism like Glut1, are also regulated by growth factor signaling and by notch signaling, indicating a crosstalk between those pathways (Zelzer et al., 1998; Vander Heiden et al., 2001; Fukuda et al., 2002; Ciofani and Zuniga-Pflucker, 2005) . Therefore, oxygen concentration should be taken into account in the forthcoming studies on cellular differentiation.
The recent advances on molecular mechanisms underlying the cellular response to oxygen variation now allow the examination of its role during normal and pathological cellular behavior and its pharmaceutical manipulation. In addition one should stress that the therapeutic use of angiogenesis inhibitors, including VEGF and prolyl hydroxylase antagonists, is likely to TEL-ARNT interferes with cellular differentiation F Nguyen-Khac et al exhibit deleterious effects both on normal differentiation and malignant cell transformation (Acker et al., 2005) .
Materials and methods
Plasmid, nucleic acids and protein methods Several plasmids used in our assays were kindly provided by the investigators: pVEGF-Luc and HIF1a (GL Semenza); ARNT (O Hankinson; Hoffman et al., 1991) . TEL, Gal 4 and UAS-reporter vectors have been described previously Lopez et al., 1999) . A myc (6 Â ) tag and an Ha tag were introduced at the amino-terminal end of HIF1a and ARNT, respectively, by PCR-mediated subcloning. Truncated ARNT proteins, lacking 171 amino acids at their carboxyterminal end, were obtained by introducing an in-frame stop codon at the Pst1 site of the human sequence. The GAL4 DNA binding domain was fused to ARNT at the same site as TEL (after amino acid 8) to obtain GAL4-ARNT. All constructs generated by PCR were checked to be devoid of unwanted modifications by sequence analyses. They are depicted in Figure 1e and were shown by Western blotting to be expressed at comparable level upon transient transfection. When appropriate, cellular extract was quantified and identical amounts of proteins were loaded. Northern blot analyses were performed using standard protocols using PCR-derived probes. Co-immunoprecipitation was performed in conditions described (Huang et al., 1996) . Anti-Myc tag and anti-Ha monoclonal antibodies were from commercial sources (Roche Diagnostics, Meylan, France).
Electrophoretic mobility shift assay DNA binding reactions were carried out by mixing 5 ml of each in vitro translation reaction in DNA binding buffer (50 mM Tris pH 7.8, 250 mM NaCl, 5 mM EDTA pH 7.5, 25% glycerol, 2.5 mM dithiothreitol) with 7.5 ng/ml poly(dI-dC) and 100 Â M18 (mutant HIF-1 binding sites: 5 0 -AGCTTGCCC TAAAAGCTGTCCAG-3 0 ), for 5 min at room temperature, followed by incubation with 150 000 c.p.m. of [ 32 P]W18 (wild-type HIF-1 binding site: 5 0 -AGCTTGCCCTACGTGC TGCTGTCTCAG-3 0 ) for 10 min at room temperature. For supershift experiments, 2 ml of antibody was added to the binding reaction, and incubated for additional 10 min at room temperature (Huang et al., 1996) . The resulting complexes were resolved in non-denaturating 5% polyacrylamide gels in 0.5% TBE buffer at 180 V for 2.5 h at þ 41C.
Transient transfection and luciferase assay
HeLa or 293T cells were transfected by the calcium phosphate co-precipitation method as described previously (Lopez et al., 1999) . Cell lysates were prepared 48 h after transfection. For hypoxia treatment, cells were incubated in a hypoxia (1% O 2 ) chamber or with 130 mM DFO (Sigma-Aldrich, Lyon, France) 16 h before harvest. Replicate transfection experiments were performed with the same DNA preparation, and experiments were performed independently at least four times. The amount of CMV promoter was kept constant by addition of empty pcDNA when appropriate. Luciferase activity was assayed using the luciferase assay system kit (Promega, Charbonnie`res, France). Normalization using a betagalactosidase expression control vector gave the same results.
Analyses of differentiation of human CD34 þ cord blood cells CD34 þ human cells were isolated from total cord blood cells using the CD34 progenitor cell isolation kit (Miltenyi Biotec, Paris, France) according to the manufacturer's instructions.
For analyses of granulocyte differentiation, CD34 cells were cultured in RTM serum-free medium in the presence of IL3 (10 ng/ml), G-CSF (15 ng/ml), SCF (10 ng/ml) and Flt3-ligand (40 ng/ml) for 4 days. At this time (day 0), cells were seeded either in high-or low-oxygen conditions in the same medium. Cell concentration was determined and cellular differentiation was monitored using the cell surface marker expressions (antibodies: PE-anti-CD14, PE-anti-CD15, FITC-anti-CD11b) and also by morphological analyses.
32Dcl3 cell culture and differentiation 32Dcl3 murine cell line was maintained in RPMI 1640 medium (Invitrogen, Cergy Pontoise, France) containing 10% fetal calf serum (FCS), antibiotics, L-glutamine and 1 ng/ml of IL3. The 32Dcl3 cells were electroporated with pCDNA and pCDNA-TEL-ARNT plasmids and selected in G-418 (1 mg/ml neomycin). TEL-ARNT-expressing pools and single-cell clones were identified by Western blot analysis using anti-ARNT antibody (serum 76). For G-CSF-induced polymorphonuclear differentiation, cells were washed three times in PBS and resuspended in RPMI 1640 medium with 10% FCS, antibiotics, L-glutamine and 10 ng/ml of human G-CSF (Neupogen, Amgen, Neuilly Sur Seine, France). For hypoxia treatment, cells were incubated at day 0 in hypoxia chambers (1% 0 2 ), and removed for cytospin and freezing on different days. The morphology of differentiating cells was determined by staining with May-Gru¨nwald-Giemsa, and cells were scored for differentiation on the basis of morphology, in duplicate everyday, with two differential counts of 100 cells by two investigators. Experiments with different clones were performed independently three times.
Fluorescene-activated cell sorter analysis was performed using fluorescene isothiocyanate (FITC)-coupled anti-CD11b or FITC coupled-IgG1/k isotype control antibody (Dako, Trappes, France).
